Haemodynamic effects of losartan an angiotensin II receptor antagonist in patients with cirrhosis and portal hypertension.

被引：0
|
作者：
Tripathi, D [1 ]
Therapondos, G [1 ]
Lui, HF [1 ]
Hayes, PC [1 ]
机构：
[1] Royal Edinburgh Infirm, Liver Unit, Edinburgh, Midlothian, Scotland
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1470
引用
收藏
页码：527A / 527A
页数：1
相关论文
共 50 条
  • [21] Effects of angiotensin II receptor antagonist losartan on microalbuminuria and blood pressure in type II diabetic patients
    Ragonesi, PD
    Belviso, A
    Taddei, MT
    JOURNAL OF HYPERTENSION, 1998, 16 : S166 - S166
  • [22] Angioedema associated with angiotensin II receptor antagonist losartan
    Sharma, PK
    Yium, JJ
    SOUTHERN MEDICAL JOURNAL, 1997, 90 (05) : 552 - 553
  • [23] PHARMACOLOGY OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN ANIMAL-MODELS OF HYPERTENSION
    SIEGL, PKS
    KIVLIGHN, SD
    BROTEN, TP
    JOURNAL OF HYPERTENSION, 1995, 13 : S15 - S21
  • [24] Effects of the angiotensin II receptor antagonist irbesartan on the endothelial function in patients with hypertension
    Koval, SN
    Mysnichenko, OV
    Maslyaeva, LV
    Starchenko, TG
    JOURNAL OF HYPERTENSION, 2000, 18 : S156 - S156
  • [25] Effects of angiotensin II and losartan in the forearm of patients with essential hypertension
    Baan, J
    Chang, PC
    Vermeij, P
    Pfaffendorf, M
    van Zwieten, PA
    JOURNAL OF HYPERTENSION, 1998, 16 (09) : 1299 - 1305
  • [26] Systemic and splanchnic effects of acute administration of losartan - A specific angiotensin II receptor antagonist - In normal and portal hypertensive rats
    Croquet, V
    Oberti, F
    Moal, F
    Wang, J
    Roux, J
    Veal, N
    Cales, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 64 - 64
  • [27] Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension
    Debernardi-Venon, W
    Barletti, C
    Alessandria, C
    Marzano, A
    Baronio, M
    Todros, L
    Saracco, G
    Repici, A
    Rizzetto, M
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (02) : 401 - 404
  • [28] Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodialting beta-blocker in patients with cirrhosis and portal hypertension.
    Tripathi, D
    Therapondos, G
    Lui, HF
    Stanley, AJ
    Hayes, PC
    HEPATOLOGY, 2000, 32 (04) : 522A - 522A
  • [29] Efficacy of Irbesartan, a Receptor Selective Antagonist of Angiotensin II, in Reducing Portal Hypertension
    Wilma Debernardi-Venon
    Claudio Barletti
    Carlo Alessandria
    Alfredo Marzano
    M. Baronio
    Luca Todros
    Giorgio Saracco
    Alessandro Repici
    Mario Rizzetto
    Digestive Diseases and Sciences, 2002, 47 : 401 - 404
  • [30] A116C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension
    Spiering, W
    Kroon, AA
    de Leeuw, PW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2601 - 2602
12345